Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Hospital Universitari de Bellvitge.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier:
NCT01268956
First received: January 3, 2011
Last updated: NA
Last verified: December 2010
History: No changes posted
  Purpose

Correlation of circulating lymphatic endothelial progenitor cells with lymph node metastasis


Condition
Ovarian Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Correlation of Circulating Lymphatic Progenitor Cells With Lymph Node Metastasis in Ovarian Cancer Patients

Resource links provided by NLM:


Further study details as provided by Hospital Universitari de Bellvitge:

Biospecimen Retention:   Samples Without DNA

blood serum


Estimated Enrollment: 60
Study Start Date: January 2011
Estimated Study Completion Date: September 2011
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Lymphatic progenitor cell
Circulating lymphatic progenitor cell
Control
healthy people

Detailed Description:

Correlation of circulating lymphatic endothelial progenitor cells with lymph node metastasis in ovarian cancer patients

  Eligibility

Ages Eligible for Study:   15 Years to 80 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

ovarian cancer patients

Criteria

Inclusion Criteria:

  • ovarian cancer patients diagnosed by pathologic examination

Exclusion Criteria:

  • other malignant disease inflammatory disease untreated diabetic and hypertension chronic renal failure rheumatoid arthritis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01268956

Contacts
Contact: Huiling Qiu Zhiqing Liang, Doctor 86-23-68754813 zhi.lzliang@gmail.com

Locations
China, Sichuan
Department of Obstetrics & Gynecology, Southwest Hospital Enrolling by invitation
Chongqing, Sichuan, China, 400038
Sponsors and Collaborators
Hospital Universitari de Bellvitge
Investigators
Principal Investigator: Pianyifan pianyifan, Doctor Southwest hospital
  More Information

No publications provided

Responsible Party: Huiling Qiu, Department of Obstetrics & Gynecology, Southwest Hospital
ClinicalTrials.gov Identifier: NCT01268956     History of Changes
Other Study ID Numbers: 20101231001
Study First Received: January 3, 2011
Last Updated: January 3, 2011
Health Authority: China: National Natural Science Foundation

Additional relevant MeSH terms:
Neoplasm Metastasis
Ovarian Neoplasms
Neoplastic Processes
Neoplasms
Pathologic Processes
Endocrine Gland Neoplasms
Neoplasms by Site
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders

ClinicalTrials.gov processed this record on July 24, 2014